262
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Factors affecting patient's perception of anticancer treatments side-effects: an observational study

, MD, , MD, , MD, , MD, , MD, , MD, , MD, , MA, , MD & , PhD MD show all

Bibliography

  • Mulders M, Vingerhoets A, Breed W. The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 2008;12:97-102
  • Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol 2011;3:57-71
  • Cleeland CS, Sloan JA. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for Standards. J Pain Symptom Manage 2010;39:1077-85
  • Stiefel F, Barth J, Bensing J, et al. Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Ann Oncol 2010;21:204-7
  • Neuss MN, Desch CE, McNiff KK, et al. A Process for Measuring the Quality of Cancer Care: the Quality Oncology Practice Initiative. J Clin Oncol 2005;23:6233-9
  • Roila F, Cortesi E. Quality of life as a primary end point in oncology. Ann Oncol 2001;12:S3-6
  • Malik IA, Khan WA, Qazilbash M, et al. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Am J Clin Oncol 1995;18:170-5
  • Roscoe JA, Morrow GR, Aapro MS, et al. Anticipatory nausea and vomiting. Support Care Cancer 2011;19:1533-8
  • Coates A, Abraham S, Kaye SB, et al. On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983;19:203-8
  • Griffin AM, Butow PN, Coates AS, et al. On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 1996;7:189-95
  • Carelle N, Piotto E, Bellanger A, et al. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002;95:155-63
  • Bosnjak S, Radulović S, Nesković-Konstantinović Z, Mitrović L. Patient statement of satisfaction with antiemetic treatment is related to quality of life. Am J Clin Oncol 2002;23:575-8
  • Hickok JT, Roscoe JA, Morrow GR, et al. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer 2003;97:2880-6
  • Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 2001;28:465-70
  • Colbourne L. Patients' experiences of chemotherapy treatment. Prof Nurse 1995;10:439-42
  • De Boer-Dennert M, De Wit R, Schmitz PI, et al. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 1997;76:1055-61
  • Lindley C, McCune JS, Thomason TE, et al. Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Pract 1999;7:59-65
  • Vogel BA, Leonhart R, Helmes AW. Communication matters: the impact of communication and participation in decision making on breast cancer patients' depression and quality of life. Patient Educ Couns 2009;77:391-7
  • Priestman TJ, Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1976;1:899-900
  • Wong RKS, Franssen E, Szumacher E, et al. What do patients living with advanced cancer and their carers want to know? - a needs assessment. Support Care Cancer 2002;10:408-15
  • Cooper S, Georgiou V. The impact of cytotoxic chemotherapy--perspectives from patients, specialists and nurses. Eur J Cancer 1992;28A(Suppl 1):S36-8
  • Ballatori E, Roila F. Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes 2003;1:46
  • Gibson RJ, Keefe DMK. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer 2006;14:890-900
  • Feld R. Endpoints in cancer clinical trials: is there a need for measuring quality of life? Support Care Cancer 1995;3:23-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.